XOMA Corporation (XOMA)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
0.46+0.01 (+1.93%)
At close: 4:00 PM EDT
People also watch:
CTICVICLIMMUVVUSAGEN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.46
Prev Close0.45
Bid0.45 x 300
Ask0.48 x 13200
Day's Range0.44 - 0.47
52wk Range0.44 - 2.03
1y Target EstN/A
Market Cap55.35M
P/E Ratio (ttm)41.73
Beta2.27
Volume1,195,898
Avg Vol (3m)860,195
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cubeyesterday

    ETF’s with exposure to XOMA Corp. : September 30, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to XOMA Corp. Here are 5 ETF’s with the largest exposure to XOMA-US. Comparing the performance and risk of XOMA Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Investopedia15 days ago

    XOMA Reports Success in Insulin Trials (XOMA)

    XOMA’s 358 trial success indicates its lead in offering the therapy for widespread insulin-related abnormalities.

  • GlobeNewswire16 days ago

    XOMA Provides Update from Ongoing Phase 2 XOMA 358 Clinical Studies

    Results Demonstrate XOMA 358 Mechanism-of-Action in Rare Endocrine Conditions Company Plans to Advance XOMA 358 to Multi-dose Phase 2 b Studies. BERKELEY, Calif., Sept. 15, 2016-- XOMA Corporation, a leader ...